A team of computer scientists from the University of Delaware and Georgetown University has developed a new system to rapidly determine which cancer drugs are likely to work best given a patient’s genetic markers. The first publicly available system of its kind, their database, eGARD (extracting Genomic Anomalies association with Response to Drugs), is described in PLOS One.
Recent News
Upcoming Seminars
Fairness and bias in biomedicine AI
Yifan Yang
September 9, 2024 | 3:30 PM
Beyond genomics: Integrative multi-omics in cancer research
Dr. Ana Robles
September 23, 2024 | 3:30 PM
Prediction of Behavioral Determinants of Health Using Domain-Specific BERT Embeddings and BiLSTM: A Study on the MIMIC-III Dataset
Saad Althabiti
September 30, 2024 | 3:30 PM
Decoding the Mystery: The Role of ABCA4 Variants in Inherited Retinal Diseases
Esther E. Biswas-Fiss, PhD, MB(ASCP)CM
September 16, 2024 | 3:30 PM